Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 3207-3210, July 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dolnick, B. J.
Right arrow Articles by Black, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dolnick, B. J.
Right arrow Articles by Black, A. R.

Alternate Splicing of the rTS Gene Product and Its Overexpression in a 5-Fluorouracil-resistant Cell Line1

Bruce J. Dolnick2 and Adrian R. Black

Department of Experimental Therapeutics and Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263

rTS is a gene with convergent and overlapping transcription relative to thymidylate synthase (TS). Screening of a cDNA library has identified a second rTS RNA (rTSß) which is related to a previously described rTS RNA (rTS{alpha}). rTSß differs from rTS{alpha} by the insertion of an extra 116 nucleotides after base 128 of rTS{alpha} and an altered 3'-noncoding region such that rTSß RNA is not complementary to TS mRNA. rTS{alpha} and rTSß RNAs have open reading frames predicted to encode proteins of 361 and 416 amino acids, respectively. Antibody to rTSß protein detects two proteins of the predicted molecular weight in the H630 colon tumor cell line. rTSß is overexpressed 40–70-fold in a 5-fluorouracil-resistant H630 subline compared with 7–8-fold for TS and rTS{alpha}.

1 Supported by Grant CA57634 (to B. J. D.) and Core Grant CA16056 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at Department of Experimental Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263-0001. Phone: (716) 845-5828; Fax: (716) 845-8857 or 845-8674; E-mail: Dolnick@SC3103.med.buffalo.edu.

Received 4/12/96. Accepted 5/29/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. Dolnick, Q. Wu, N. J. Angelino, L. V. Stephanie, K.-C. Chow, J. R. Sufrin, and B. J. Dolnick
Enhancement of 5-Fluorouracil Sensitivity by an rTS Signaling Mimic in H630 Colon Cancer Cells
Cancer Res., July 1, 2005; 65(13): 5917 - 5924.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Q. Wu and B. J. Dolnick
Detection of Thymidylate Synthase Modulators by a Novel Screening Assay
Mol. Pharmacol., January 1, 2003; 63(1): 167 - 173.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.